About Paragraf
Paragraf is a company based in Peterborough (United Kingdom) founded in 2015 by Ivor Guiney, Colin John Humphreys, and Simon Thomas. Paragraf has raised $139.55 million across 7 funding rounds from investors including Gov.uk, Cambridge Enterprise and Martlet Capital. Paragraf has completed 1 acquisition, including Cardea Bio. Paragraf operates in a competitive market with competitors including Xsensio, Feelit, Nano New Energy, Nanogate and Quantum Precision Instruments, among others.
- Headquarter Peterborough, United Kingdom
- Founders Ivor Guiney, Colin John Humphreys, Simon Thomas
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paragraf Limited
- Date of Incorporation 25 Nov, 2015
- Jurisdiction SOMERSHAM, CAMBRIDGESHIRE, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$139.55 M (USD)
in 7 rounds
-
Latest Funding Round
$55 M (USD), Series C
Aug 25, 2025
-
Investors
Gov.uk
& 12 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Paragraf
Unlock access to complete
Unlock access to complete
Funding Insights of Paragraf
Paragraf has successfully raised a total of $139.55M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $55 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Paragraf
Paragraf has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Cambridge Enterprise and Martlet Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early, mid, and late-stage investments are made in science sectors.
|
Locked | Locked | Locked | |
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Locked | Locked | Locked | |
|
Early-stage deep technology investments are made by Amadeus Capital.
|
Locked | Locked | Locked |
Investor details for Paragraf
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paragraf
Paragraf has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cardea Bio.
Investment portfolio details for Paragraf
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Digital graphene biosensors are developed using machine learning.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Paragraf
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Paragraf
Detailed financials for Paragraf
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paragraf Comparisons
Peer comparison for Paragraf
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paragraf
Paragraf operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xsensio, Feelit, Nano New Energy, Nanogate and Quantum Precision Instruments, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable biosensors are manufactured for skin-based biochemical analysis.
|
|
| Locked | Locked | Locked |
Nano-material sensing solutions for structural parameters are provided.
|
|
| Locked | Locked | Locked |
Nanotechnology for energy storage is developed and produced.
|
|
| Locked | Locked | Locked |
Magnetic nano-sized sensors are developed by Nanogate.
|
|
| Locked | Locked | Locked |
Developed advanced nanotechnology sensors and devices for various industrial markets.
|
Detailed competitors of Paragraf
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paragraf
Complete news archive for Paragraf
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragraf
Paragraf was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Paragraf is headquartered in Peterborough, United Kingdom.
Simon Thomas is the current CEO of Paragraf. They have also founded this company.
Paragraf is a funded company, having raised a total of $139.55M across 7 funding rounds to date.
Paragraf was founded in 2015 in Peterborough, United Kingdom, focusing on advanced materials in the sensor industry. Graphene solutions are created through a proprietary two-dimensional material manufacturing process. The product range encompasses hall-effect sensors, biosensors, and solid-state devices, with attributes such as hardness, bendability, and absorbency across UV and visible spectra. Operations center on providing these technologies for various applications.
Paragraf's top competitors include Feelit, Xsensio and Nano New Energy.
Paragraf has made 1 acquisition, including Cardea Bio.
Paragraf has 13 investors. Key investors include Gov.uk, Cambridge Enterprise, Martlet Capital, Molten Ventures, and Draper Esprit.